NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer

SIMPLE SUMMARY: Despite several limitations, imaging is still the gold standard in evaluating the treatment effect in metastatic colorectal cancer, and the best response is often achieved several months after treatment start. The present study investigated methylated circulating tumor DNA (ctDNA) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Raunkilde, Louise, Hansen, Torben Frøstrup, Andersen, Rikke Fredslund, Havelund, Birgitte Mayland, Thomsen, Caroline Brenner, Jensen, Lars Henrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496936/
https://www.ncbi.nlm.nih.gov/pubmed/36139621
http://dx.doi.org/10.3390/cancers14184459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496936/
https://www.ncbi.nlm.nih.gov/pubmed/36139621
http://dx.doi.org/10.3390/cancers14184459

Ejemplares similares